ITT Labs located in Birmingham, Alabama specializes in the individualized treatment of cancer patients through cancer genomics, enzymatic assays, and pharmacogenetics. Laboratory services include:

• Assisting clinical oncologists in translating the emerging knowledge of “molecular markers” to the clinical practice to provide a less empirical and more rational, individualized approach to patient treatment; using enzymatic, mutation detection, gene expression, and drug sensitivity assays to predict patient response and toxicity to commonly prescribed chemotherapy drugs.
  
  
• Performing enzymatic assays to assist in drug development, preclinical and clinical trials.
  
  
• Researching and developing new technologies in the personalized treatment of cancer patients.